Seeking Alpha

Covidien (COV +2.2%) trades higher after announcing the FDA has issued a clearance for the...

Covidien (COV +2.2%) trades higher after announcing the FDA has issued a clearance for the company's SpiderFX, an embolic protection device for the treatment of severely calcified arterial lesions in the lower extremities.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs